Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA
نویسندگان
چکیده
منابع مشابه
the past hospitalization and its association with suicide attempts and ideation in patients with mdd and comparison with bmd (depressed type) group
چکیده ندارد.
Efficacy and Safety of Roflumilast in Korean Patients with COPD
PURPOSE Roflumilast is the only oral phosphodiesterase 4 inhibitor approved to treat chronic obstructive pulmonary disease (COPD) patients [post-bronchodilator forced expiratory volume in 1 second (FEV₁) <50% predicted] with chronic bronchitis and a history of frequent exacerbations. This study evaluated the efficacy and safety of roflumilast in Korean patients with COPD and compared the effica...
متن کاملVulnerable COPD patients with comorbidities: the role of roflumilast
Roflumilast is a selective phosphodiesterase-4 (PDE-4) inhibitor that was approved by the US Food and Drug Administration in February 2011 for the management of chronic obstructive pulmonary disease (COPD). Literature was retrieved through PubMed using the terms "roflumilast" and "COPD". Reference citations from publications identified were also reviewed. All articles published in English using...
متن کاملComparing Home-based Pulmonary Rehabilitation Nursing on Fatigue and quality of life in Patients with COPD
Background & Objective:The aim of the present study is to compare the effects of home-based pulmonary rehabilitation nursing care on Fatigue and QOL in patients with COPD. Materials & Methods: This study was a semi experimental research. The samples were consisted of 36 patients who were selected based on inclusion and exclusion criteria into control and experimental groups through random...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Chronic Obstructive Pulmonary Disease
سال: 2018
ISSN: 1178-2005
DOI: 10.2147/copd.s159827